Unitaid audited financial report for the year ended 31 December 2021
Unitaid Strategy 2023-2027
Financial Guidelines for Unitaid Grant Implementers (Frequently Asked Questions)
Unitaid 2017-2021 Strategy Review, Management Response, Dec 2021
Unitaid 2017-2021 Strategy Review, Final Report, Vol 2, Annexes
Unitaid 2017-202 Strategy Review, Final Report, Vol 1, Main report
Multipurpose prevention technologies: Technology landscape and potential for low- and middle-income countries
Financial guidelines for Unitaid grant implementers
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Building climate-resilient, sustainable, and low-carbon health supply chains: key priorities for collective action
Gonorrhea point-of-care diagnostics technology and market landscape
Screening and treatment of precancerous lesions for secondary prevention of cervical cancer
Landscape report on commodity and service delivery innovations for detection and management of pre-eclampsia
Medical oxygen innovation landscape
The untold story of dolutegravir: When climate impact goes hand-in-hand with access to better treatments
Antimalarial manufacturing in Africa: A call for regional action
Enabling a market-based approach to manufacturing quality-assured health products in Africa: A differentiated coordination approach
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
Malaria vector control commodities technology and market landscape – 2nd edition
Tuberculosis diagnostics technology & market landscape – semi-annual update
Malaria diagnostics market landscape – semi-annual update
HIV/AIDS diagnostics technology landscape – semi-annual update
Hepatitis C medicines and diagnostics in the context of HIV/HCV co-infection: a scoping report
Tuberculosis medicines technology and market landscape – 1st edition
HIV preventives technology and market landscape – 1st edition
Tuberculosis diagnostics technology and market landscape – 2nd edition
